Correlation Between Inhibrx and Passage Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Passage Bio, you can compare the effects of market volatilities on Inhibrx and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Passage Bio.

Diversification Opportunities for Inhibrx and Passage Bio

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Inhibrx and Passage is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Inhibrx i.e., Inhibrx and Passage Bio go up and down completely randomly.

Pair Corralation between Inhibrx and Passage Bio

Given the investment horizon of 90 days Inhibrx is expected to generate 0.44 times more return on investment than Passage Bio. However, Inhibrx is 2.29 times less risky than Passage Bio. It trades about -0.01 of its potential returns per unit of risk. Passage Bio is currently generating about -0.08 per unit of risk. If you would invest  1,514  in Inhibrx on December 29, 2024 and sell it today you would lose (82.00) from holding Inhibrx or give up 5.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Passage Bio

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Passage Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Inhibrx and Passage Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Passage Bio

The main advantage of trading using opposite Inhibrx and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.
The idea behind Inhibrx and Passage Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators